OBI.L Stock - Ondine Biomedical Inc.
Unlock GoAI Insights for OBI.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.05M | $1.20M | $638,000 | $2.57M | $1.79M |
| Gross Profit | $1.32M | $703,000 | $287,000 | $1.25M | $649,000 |
| Gross Margin | 64.5% | 58.4% | 45.0% | 48.8% | 36.2% |
| Operating Income | $-19,444,000 | $-14,805,000 | $-18,763,000 | $-17,520,000 | $-15,871,000 |
| Net Income | $-19,098,000 | $-14,412,000 | $-19,372,000 | $-50,085,000 | $-16,271,000 |
| Net Margin | -932.1% | -1198.0% | -3036.4% | -1949.6% | -908.5% |
| EPS | $-0.07 | $-0.07 | $-0.10 | $-0.26 | $-0.08 |
Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; OND1002, a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and OND1003, a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.
Visit WebsiteEarnings History & Surprises
OBI.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 15, 2025 | — | — | — | — |
Q3 2024 | Sep 30, 2024 | — | — | — | — |
Q2 2024 | Jun 29, 2024 | — | $-0.02 | — | — |
Q2 2024 | Jun 7, 2024 | — | — | — | — |
Q1 2024 | Feb 28, 2024 | — | — | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.02 | — | — |
Q3 2023 | Aug 10, 2023 | — | — | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.04 | — | — |
Q3 2022 | Sep 27, 2022 | — | $-0.03 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.03 | — | — |
Q2 2011 | Jun 30, 2011 | — | $-0.08 | — | — |
Q1 2011 | Mar 31, 2011 | — | $-0.07 | — | — |
Q4 2010 | Dec 31, 2010 | — | $-0.05 | — | — |
Q3 2010 | Sep 30, 2010 | — | $-0.00 | — | — |
Q2 2010 | Jun 30, 2010 | — | $-0.07 | — | — |
Q1 2010 | Mar 31, 2010 | — | $-0.11 | — | — |
Q4 2009 | Dec 31, 2009 | — | $-0.10 | — | — |
Q3 2009 | Sep 30, 2009 | — | $-0.01 | — | — |
Q2 2009 | Jun 30, 2009 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about OBI.L
What is OBI.L's current stock price?
What is the analyst price target for OBI.L?
What sector is Ondine Biomedical Inc. in?
What is OBI.L's market cap?
Does OBI.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to OBI.L for comparison